Keros Therapeutics share price logo

Keros Therapeutics

NASDAQ: KROS

$11.95

+0.31

(+2.66%)

as on

Keros Therapeutics Stock Performance

as on October 10, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $11.49
    $12.26
    downward going graph

    3.85%

    Downside

    2.59%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $9.69
    $22.55
    downward going graph

    18.91%

    Downside

    88.70%

    Upside

    downward going graph

Keros Therapeutics share price movements today

Previous Close
$11.64
Open
$11.49
Volume
281.1K
Market Cap
$230.8M
Day's Low - High
$11.49 - $12.26
52 Week Low - High
$9.69 - $22.55

Keros Therapeutics Historical Returns

1 Month Return
+ 6.98 %
3 Month Return
+ 1.27 %
1 Year Return
-23.89 %
3 Year Return
-60.65 %
5 Year Return
-67.66 %

Keros Therapeutics Stock Fundamentals & Key Indicators

Check Keros Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$230.8M

EPS (TTM)

-3.7

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.15

Industry PE ratio

-3.02

PEG Ratio

0.00

EBITDA

-84.5M

Revenue (TTM)

15.0M

Profit Margin

94.68%

Return On Equity TTM

-21.40%

Keros Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Keros Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Keros Therapeutics image
Keros Therapeutics
Buy$230.8M-67.66%-3.1594.68%0.00%
Moderna image
Moderna
Neutral$78.6B-26.21%-24.69-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$127.6B185.06%29.0686.04%0.00%
Regeneron image
Regeneron
Buy$76.4B35.73%17.6684.86%0.50%

Stock Returns calculator for Keros Therapeutics Stock including INR - Dollar returns

The Keros Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Keros Therapeutics investment value today

Current value as on today

₹82,995

Returns

-₹17,005

(-17.01%)

Returns from Keros Therapeutics Stock

-₹23,885 (-23.89%)

Dollar Impact

₹6,880 (+6.88%)

Analyst Recommendation on Keros Therapeutics Stock

Based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Keros Therapeutics. Average target price of $19.83

Keros Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Keros Therapeutics.

What analysts predicted

39.74%UPSIDE

Target Price

$19.83

Current Price

$11.95

Analyzed by

3 Analysts

High

$23

Target

$19.83

Low

$17

Keros Therapeutics target price $19.83, a slight upside of 39.74% compared to current price of $11.95. According to 3 analysts rating.

Indian Investors' Interest in Keros Therapeutics Stock

Search interest for Keros Therapeutics Stock has increased by 84% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:84% versus previous 30 day period

Keros Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
3
211
18
14
0
0
-
Gross Profit
0
0
0
2
211
17
13
0
0
-
Operating Income
-48
-50
-58
-53
152
-39
-15
-29
-25
-30
EBITDA
-42
-44
-52
-29
158
-32
-8
-24
-23
-28
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-43
-45
-52
-45
158
-32
-8
-24
-23
-28
Income Tax Expense
-
-
-
0
10
-2
-1
-1
-
-
Net Income
-43
-45
-52
-46
148
-30
-7
-23
-23
-28
Net Profit Margin
100.00%
100.00%
19.07%
89.09%
100.00%
97.96%
97.23%
100.00%
-9.81%
0.00%

Keros Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
10
10
-
20
-
0
3
244
Gross Profit
0
-7
0
20
-
0
3
242
Operating Income
-1
-10
-46
-56
-114
-169
-210
70
EBITDA
-1
-11
-45
-56
-104
-152
-185
93
Interest Expense
-
0
0
0
0
-
-
-
Depreciation
0
0
0
0
0
0
1
1
Income Before Tax
-1
-12
-45
-56
-104
-152
-187
91
Income Tax Expense
0
-
0
2
-
-
0
4
Net Income
-1
-12
-45
-58
-104
-152
-187
87
Net Profit Margin
-1.11%
-73.48%
0.00%
100.00%
0.00%
100.00%
100.00%
99.38%

Keros Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-43
-45
-52
-46
148
-30
-7
-23
-23
-28
Operating Cash Flow
-44
-39
-30
-46
161
-29
3
-27
-3
-20
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
156
3
155
75
0
0
0
-378
-2
-3
Change in Cash
111
-36
125
29
160
-30
3
-406
-5
-23

Keros Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-12
-45
-58
-104
-152
-187
87
Operating Cash Flow
7
-15
-36
-62
-70
-124
-160
107
Investing Cash Flow
0
0
0
-1
-1
-2
-1
-1
Financing Cash Flow
11
0
296
28
120
178
391
-378
Change in Cash
18
-16
258
-34
49
51
229
-272

Global Institutional Holdings in Keros Therapeutics

Check out the Institutions with significant holdings in Keros Therapeutics.

Funds
Holdings
iShares
5.11%
Vanguard
5.06%
VANGUARD INDEX FUNDS
4.10%
Federated Hermes MDT Series
2.51%
Fidelity Salem Street Trust
1.66%
See all

Keros Therapeutics News & Key Events

  • img

    Today's Timeline - 29 September

    Tue, 05:35 PM

    -

    Keros Therapeutics to receive $20 million milestone payment from Takeda after first patient dosing in Phase 3 myelofibrosis trial.

Insights on Keros Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, KROS stock has moved up by 5.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 119.0% return, outperforming this stock by 178.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 762.5%

About Keros Therapeutics

Keros Therapeutics, Inc., a biopharmaceutical entity in the clinical development phase, is focused on pioneering and commercializing innovative therapies for individuals afflicted by hematological and musculoskeletal conditions that currently lack adequate treatment options. Its flagship protein therapeutic, KER-050, is being advanced to address diminished blood cell counts (cytopenias), specifically anemia and thrombocytopenia, in patients diagnosed with myelodysplastic syndromes and myelofibrosis. Furthermore, the company is progressing KER-047, a small molecule designed to combat anemia, which is presently undergoing Phase 1 clinical evaluation. Another small molecule, KER-012, is also in Phase 1 clinical trials for treating ailments characterized by bone degeneration, such as osteoporosis and osteogenesis imperfecta, alongside pulmonary arterial hypertension. Founded in 2015, the firm maintains its principal operations in Lexington, Massachusetts.
OrganisationKeros Therapeutics
Headquarters1050 Waltham Street, Lexington, MA, 02421, US
IndustryBiotechnology
CEOJasbir S. Seehra

Key Management of Keros Therapeutics

Name

Title

Ms. Annita Tanini

VP of Finance, Corporate Controller and Interim Principal Financial & Accounting Officer

Justin Frantz

Head of Investor Relations

Dr. Lorena Lerner Ph.D.

Chief Scientific Officer

Dr. Jasbir S. Seehra Ph.D.

President, CEO & Director

Ms. Esther Cho J.D.

Chief Legal Officer & Secretary

FAQs

What is Keros Therapeutics share price today?

Keros Therapeutics share price today is $11.95 as on at the close of the market. Keros Therapeutics share today touched a day high of $12.26 and a low of $11.49.

What is the 52 week high and 52 week low for Keros Therapeutics share?

Keros Therapeutics share touched a 52 week high of $22.55 on and a 52 week low of $9.69 on . Keros Therapeutics stock price today i.e. is closed at $11.95,which is 47.01% down from its 52 week high and 23.32% up from its 52 week low.

What is Keros Therapeutics's market capitalisation today?

Keros Therapeutics market capitalisation is $0.00T as on .

How to invest in Keros Therapeutics Stock (KROS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Keros Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Keros Therapeutics Stock (KROS) from India?

Indian investors can start investing in Keros Therapeutics (KROS) shares with as little as ₹96.779998779297 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in Keros Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Keros Therapeutics share’s latest price of $11.95 as on October 10, 2026 at 8:46 am IST, you will get 0.8368 shares of Keros Therapeutics. Learn more about fractional shares .

What are the returns that Keros Therapeutics has given to Indian investors in the last 5 years?

Keros Therapeutics stock has given -67.66% share price returns and 28.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?